X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
15
PharmaCompass offers a list of Megestrol Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Megestrol Acetate manufacturer or Megestrol Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Megestrol Acetate manufacturer or Megestrol Acetate supplier.
PharmaCompass also assists you with knowing the Megestrol Acetate API Price utilized in the formulation of products. Megestrol Acetate API Price is not always fixed or binding as the Megestrol Acetate Price is obtained through a variety of data sources. The Megestrol Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Megestrol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Megestrol Acetate, including repackagers and relabelers. The FDA regulates Megestrol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Megestrol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Megestrol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Megestrol Acetate supplier is an individual or a company that provides Megestrol Acetate active pharmaceutical ingredient (API) or Megestrol Acetate finished formulations upon request. The Megestrol Acetate suppliers may include Megestrol Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Megestrol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Megestrol Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Megestrol Acetate active pharmaceutical ingredient (API) in detail. Different forms of Megestrol Acetate DMFs exist exist since differing nations have different regulations, such as Megestrol Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Megestrol Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Megestrol Acetate USDMF includes data on Megestrol Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Megestrol Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Megestrol Acetate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Megestrol Acetate Drug Master File in Korea (Megestrol Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Megestrol Acetate. The MFDS reviews the Megestrol Acetate KDMF as part of the drug registration process and uses the information provided in the Megestrol Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Megestrol Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Megestrol Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Megestrol Acetate suppliers with KDMF on PharmaCompass.
A Megestrol Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Megestrol Acetate Certificate of Suitability (COS). The purpose of a Megestrol Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Megestrol Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Megestrol Acetate to their clients by showing that a Megestrol Acetate CEP has been issued for it. The manufacturer submits a Megestrol Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Megestrol Acetate CEP holder for the record. Additionally, the data presented in the Megestrol Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Megestrol Acetate DMF.
A Megestrol Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Megestrol Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Megestrol Acetate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Megestrol Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Megestrol Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Megestrol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Megestrol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Megestrol Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Megestrol Acetate suppliers with NDC on PharmaCompass.
Megestrol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Megestrol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Megestrol Acetate GMP manufacturer or Megestrol Acetate GMP API supplier for your needs.
A Megestrol Acetate CoA (Certificate of Analysis) is a formal document that attests to Megestrol Acetate's compliance with Megestrol Acetate specifications and serves as a tool for batch-level quality control.
Megestrol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Megestrol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Megestrol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Megestrol Acetate EP), Megestrol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Megestrol Acetate USP).
Market Place
